Dr Reddy’s Laboratories: Biotechnology company Coya Therapeutics announced a worldwide agreement with Dr Reddy’s Laboratories to in-license the proposed Abatacept biosimilar of Dr Reddy’s for the development of Coya’s combination product for neurodegenerative diseases, COYA 302.
Rail Vikas Nigam: The company on Monday said it has signed a Memorandum of Understanding (MOU) with Noida- headquartered infrastructure and renewable firm Jakson Green for clean energy engineering, procurement and construction (EPC) projects, globally.
Adani Enterprises: The company on Monday said that it has decided to keep the major equipment procurement and site construction activities on hold for its green PVC project.
Kotak Mahindra bank: The bank has raised Rs 300 crore as it allotted 30,000 non-convertible bonds in the nature of debentures, of the face value Rs 1 lakh each, on private placement basis.
Dwarikesh Sugar Industries: The company’s board has announced an interim dividend of Rs 2 per share for the financial year 2022- 23. The interim dividend outgo will be Rs 37.66 crore. The record date for the shareholders who will be entitled to receive the said dividend will be March 31, 2023.
HDFC Asset Management Company: SBI Mutual Fund has bought 47.33 lakh shares in the AMC via open market transactions at an average price of Rs 1,600 per share, amounting to Rs 757.4 crore.